Mechanism of melatonin regulating the expression level of rhythm genes to alleviate interstitial pulmonary fibrosis.
- Author:
Bingle LI
1
;
Lingyan ZHU
2
;
Yongfu WANG
2
;
Li BAI
3
Author Information
1. Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, Inner Mongolia, China.
2. Department of Rheumatology and Immunology, the First Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mongolia, China.
3. The Central Lab, the First Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mongolia, China.
- Publication Type:Journal Article
- Keywords:
Melatonin;
Pulmonary fibrosis;
Rhythm genes
- MeSH:
Melatonin/pharmacology*;
Animals;
Mice;
Pulmonary Fibrosis/chemically induced*;
Bleomycin;
Humans;
Transforming Growth Factor beta/metabolism*;
Period Circadian Proteins/metabolism*;
Smad3 Protein/genetics*;
Disease Models, Animal;
Lung/pathology*;
Cryptochromes/metabolism*;
Smad2 Protein/genetics*;
Epithelial Cells/metabolism*;
Mice, Inbred C57BL
- From:
Journal of Peking University(Health Sciences)
2024;56(6):963-971
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the intervention of melatonin (MT) in the expression of circadian genes in patients with pulmonary fibrosis and to analyze the mechanism by which it alleviates the progression of pulmonary fibrosis.
METHODS:By utilizing the Gene Expression Omnibus (GEO) database, we identified differentially expressed circadian genes between patients with pulmonary fibrosis and controls. We analyzed the correlation between circadian genes and pulmonary function as well as genes related to pulmonary fibrosis. A bleomycin-induced mouse model of pulmonary fibrosis (BLM group) was constructed to observe the expression differences of PER2 and CRY2 by sequencing and immunohistochemical staining in the BLM group and after MT intervention (BLM+MT group). Hematoxylin and eosin (HE) staining and Masson staining were used to observe the effects of MT on fibrosis. We used Western blot to detect the expression of P-smad2/3 in lung epithelial cells induced by transforming growth factor β (TGF-β). Reverse transcription quantitative real-time PCR technology was employed to investigate the rhythmic expression changes of circadian genes in the control group, TGF-β group, and TGF-β+MT group. Finally, luzindole, a MT receptor antagonist, was used to intervene in TGF-β+MT group, and Western blot was used to explore the receptor dependence of MT in alleviating TGF-β-induced epithelial-mesenchymal transition.
RESULTS:(1) Analysis of the GEO dataset (GSE) revealed a negative correlation between circadian genes PER2 and CRY2 and the expression of TGF-β, and a positive correlation with pulmonary function indicators in patients. (2) Transcriptome sequencing analysis of lung tissue in BLM group found that the expression of PER2 and CRY2 was significantly reduced compared with the normal group. Histopathological staining results showed that the lung tissue structure of the normal group was intact and clear, with thin alveolar septa; in the BLM group, there was a large increase in collagen fibers and disordered alveolar structure; compared with the BLM group, the BLM+MT group had reduced collagen fiber proliferation and inflammatory cell infiltration; the expression of PER2 and CRY2 in the BLM group was lower than in the normal group, and the expression in the BLM+MT group was increased compared with the BLM group. (3) In vitro lung epithelial cell experiments with TGF-β intervention showed that compared with the control group, the expression of P-smad2/3 increased in the TGF-β group, and MT intervention inhibited the inducing effect of TGF-β on P-smad2/3, while intervention with the MT receptor antagonist reversed this phenomenon. The results indicated that MT could inhibit the activation of the TGF-β pathway, and this process was dependent on MT receptors. (4) The 48-hour rhythm experiment in lung epithelial cells showed that the mRNA rhythm of PER2 and CRY2 in the TGF-β+MT group was close to 24 hours and showed a trend towards restoring the rhythm of the control group, while the addition of the MT receptor blocker tended to make the rhythm duration and amplitude of both groups approach that of the TGF-β group.
CONCLUSION:MT, by binding to its receptors, can restore the periodic expression of the circadian genes PER2 and CRY2, thereby inhibiting the activation of the TGF-β classical pathway and suppressing the pathological process of epithelial-mesenchymal transition in pulmonary fibrosis. This finding provides new molecular targets and potential therapeutic strategies for the treatment of pulmonary fibrosis.
